$437.05 Million in Sales Expected for Allscripts Healthcare Solutions Inc (MDRX) This Quarter

Share on StockTwits

Analysts expect that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will announce sales of $437.05 million for the current quarter, Zacks Investment Research reports. Ten analysts have provided estimates for Allscripts Healthcare Solutions’ earnings. The highest sales estimate is $447.60 million and the lowest is $431.70 million. Allscripts Healthcare Solutions posted sales of $518.60 million in the same quarter last year, which would indicate a negative year over year growth rate of 15.7%. The business is expected to announce its next quarterly earnings report after the market closes on Thursday, May 2nd.

On average, analysts expect that Allscripts Healthcare Solutions will report full year sales of $1.79 billion for the current financial year, with estimates ranging from $1.73 billion to $1.84 billion. For the next financial year, analysts anticipate that the firm will post sales of $1.85 billion, with estimates ranging from $1.79 billion to $1.92 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its earnings results on Thursday, February 21st. The software maker reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.01). The business had revenue of $538.00 million during the quarter, compared to the consensus estimate of $565.52 million. Allscripts Healthcare Solutions had a net margin of 18.15% and a return on equity of 7.74%. The firm’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period last year, the business posted $0.18 EPS.

Several brokerages have recently issued reports on MDRX. Zacks Investment Research lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, April 10th. BidaskClub lowered shares of Allscripts Healthcare Solutions from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 2nd. Finally, ValuEngine lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, December 25th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. Allscripts Healthcare Solutions currently has an average rating of “Hold” and a consensus price target of $14.35.

In related news, insider Brian Farley sold 6,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, January 18th. The shares were sold at an average price of $12.00, for a total transaction of $72,000.00. Following the transaction, the insider now owns 235,673 shares of the company’s stock, valued at approximately $2,828,076. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.10% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. boosted its stake in Allscripts Healthcare Solutions by 2,814.2% during the 1st quarter. Meeder Asset Management Inc. now owns 98,149 shares of the software maker’s stock worth $936,000 after acquiring an additional 94,781 shares during the last quarter. Sciencast Management LP acquired a new stake in shares of Allscripts Healthcare Solutions in the first quarter valued at approximately $385,000. Virtu Financial LLC acquired a new stake in shares of Allscripts Healthcare Solutions in the first quarter valued at approximately $213,000. Peregrine Capital Management LLC raised its holdings in shares of Allscripts Healthcare Solutions by 7.8% in the first quarter. Peregrine Capital Management LLC now owns 1,343,186 shares of the software maker’s stock valued at $12,814,000 after purchasing an additional 97,081 shares during the last quarter. Finally, MUFG Securities EMEA plc acquired a new stake in shares of Allscripts Healthcare Solutions in the fourth quarter valued at approximately $2,346,000.

Shares of NASDAQ MDRX traded up $0.03 during mid-day trading on Thursday, hitting $9.71. The company’s stock had a trading volume of 1,601,192 shares, compared to its average volume of 2,413,405. The firm has a market capitalization of $1.65 billion, a PE ratio of 17.65, a price-to-earnings-growth ratio of 1.87 and a beta of 1.30. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.41. Allscripts Healthcare Solutions has a one year low of $8.54 and a one year high of $14.97.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Further Reading: Is the QQQ ETF safe?

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Monolithic Power Systems  Lowered to “Hold” at BidaskClub
Monolithic Power Systems Lowered to “Hold” at BidaskClub
NPER  Achieves Market Capitalization of $200,708.00
NPER Achieves Market Capitalization of $200,708.00
Bausch Health Companies  Downgraded to “Sell” at ValuEngine
Bausch Health Companies Downgraded to “Sell” at ValuEngine
Innophos  Cut to “Sell” at BidaskClub
Innophos Cut to “Sell” at BidaskClub
Bed Bath & Beyond  Lowered to Sell at BidaskClub
Bed Bath & Beyond Lowered to Sell at BidaskClub
Mindexcoin  Market Capitalization Hits $1.06 Million
Mindexcoin Market Capitalization Hits $1.06 Million


© 2006-2019 Ticker Report